Position in RYTM
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$184,713,060
+$44,205,546 QoQ
Shares Held
1,663,632
+3.0% QoQ
Ownership
2.42%
of shares outstanding
% of Portfolio
0.53%
of 13F equity value
Holder Rank
#14
of 302 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Polar Capital Holdings Plc holds $3,774,805,029 across 41 Biotechnology names. RYTM ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ELVN |
Enliven Therapeutics, Inc.
|
6,430,636 | $326,354,777 | |
| 2 | XENE |
Xenon Pharmaceuticals Inc.
|
4,570,556 | $275,878,760 | |
| 3 | CYTK |
Cytokinetics Inc
|
2,253,649 | $191,988,358 | |
| 4 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
1,663,632 | $184,713,060 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
6,606,945 | $173,234,097 | |
| 6 | ASND |
Ascendis Pharma A/S
|
616,908 | $164,541,701 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
2,063,609 | $153,697,598 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
482,751 | $145,322,533 |
All Filings in RYTM
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $184,713,060 | 1,663,632 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $140,507,514 | 1,615,586 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $126,884,359 | 1,185,392 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $125,725,682 | 1,244,932 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $79,042,475 | 1,250,870 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $26,485,000 | 500,000 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $83,970,000 | 1,500,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $78,585,000 | 1,500,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $61,590,000 | 1,500,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $64,995,000 | 1,500,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $80,447,500 | 1,750,000 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $57,312,500 | 2,500,000 | Shares | Defined | 2023-11-22 | |
| 2023-06-30 | $37,102,500 | 2,250,000 | Shares | Defined | 2023-12-13 | |
| 2023-03-31 | $31,220,000 | 1,750,000 | Shares | Defined | 2023-12-13 | |
| 2022-12-31 | $36,400,000 | 1,250,000 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $17,511,105 | 714,739 | Shares | Defined | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||